Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Yan Zhuang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 17 Article
-
DBeQ derivative targets vacuolar protein sorting 4 functions in cancer cells and suppresses tumor growth in mice
Fundora, K. A., Zhuang, Y., Hamamoto, K., Wang, G., Chen, L., Hattori, T., Liang, X., Bao, L., Vangala, V., Tian, F., Takahashi, Y. & Wang, H. G., Apr 2025, In: Journal of Pharmacology and Experimental Therapeutics. 392, 4, 103524.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
Opaganib Protects against Radiation Toxicity: Implications for Homeland Security and Antitumor Radiotherapy
Maines, L. W., Schrecengost, R. S., Zhuang, Y., Keller, S. N., Smith, R. A., Green, C. L. & Smith, C. D., Nov 2022, In: International journal of molecular sciences. 23, 21, 13191.Research output: Contribution to journal › Article › peer-review
Open Access6 Link opens in a new tab Scopus citations -
In vitro and in vivo antitumor and anti-inflammatory capabilities of the novel GSK3 and CDK9 inhibitor ABC1183s
Schrecengost, R. S., Green, C. L., Zhuang, Y., Keller, S. N., Smith, R. A., Maines, L. W. & Smith, C. D., Apr 2018, In: Journal of Pharmacology and Experimental Therapeutics. 365, 1, p. 107-116 10 p.Research output: Contribution to journal › Article › peer-review
Open Access16 Link opens in a new tab Scopus citations -
A phase I study of ABC294640, a first-in-class sphingosine kinase-2 inhibitor, in patients with advanced solid tumors
Britten, C. D., Garrett-Mayer, E., Chin, S. H., Shirai, K., Ogretmen, B., Bentz, T. A., Brisendine, A., Anderton, K., Cusack, S. L., Maines, L. W., Zhuang, Y., Smith, C. D. & Thomas, M. B., Aug 15 2017, In: Clinical Cancer Research. 23, 16, p. 4642-4650 9 p.Research output: Contribution to journal › Article › peer-review
Open Access145 Link opens in a new tab Scopus citations -
Attenuation of arthritis in rodents by a novel orally-available inhibitor of sphingosine kinase
Fitzpatrick, L. R., Green, C., Frauenhoffer, E., French, K. J., Zhuang, Y., Maines, L. W., Upson, J. J., Paul, E., Donahue, H., Mosher, T. & Smith, C., Apr 2011, In: Inflammopharmacology. 19, 2, p. 75-87 13 p.Research output: Contribution to journal › Article › peer-review
43 Link opens in a new tab Scopus citations